March 8, 2018 / 1:13 PM / 5 months ago

BRIEF-Clovis Oncology Announces Notice Of Allowance For Rucaparib High Dosage Strength Tablet Patent With Expiration In 2035

March 8 (Reuters) - Clovis Oncology Inc:

* CLOVIS ONCOLOGY ANNOUNCES NOTICE OF ALLOWANCE FOR RUCAPARIB HIGH DOSAGE STRENGTH TABLET PATENT WITH EXPIRATION IN 2035 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below